Opko Health, Inc.
OPK
$1.13
$0.021.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -16.34% | -2.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -16.34% | -2.12% | |||
| Cost of Revenue | -30.74% | -11.12% | |||
| Gross Profit | 37.65% | 57.72% | |||
| SG&A Expenses | -11.97% | 2.62% | |||
| Depreciation & Amortization | -0.47% | -2.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.49% | -6.69% | |||
| Operating Income | -18.60% | 19.62% | |||
| Income Before Tax | -29.92% | -213.25% | |||
| Income Tax Expenses | 60.99% | -179.11% | |||
| Earnings from Continuing Operations | -75.47% | -244.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -75.47% | -244.50% | |||
| EBIT | -18.60% | 19.62% | |||
| EBITDA | -39.59% | 32.93% | |||
| EPS Basic | -77.21% | -246.76% | |||
| Normalized Basic EPS | -12.65% | 13.43% | |||
| EPS Diluted | -74.64% | -248.92% | |||
| Normalized Diluted EPS | -12.65% | 13.07% | |||
| Average Basic Shares Outstanding | -0.87% | -1.50% | |||
| Average Diluted Shares Outstanding | -0.87% | -1.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||